SAPT Versus DAPT in Incomplete Revascularization After CABG
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 800 participants.
Also called NCT03789916
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 800 participants
- Sponsor
- Registry
-
NCT03789916
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Recruiting
Technical summary
Registry record NCT03789916. Randomized; no masking; primary purpose treatment. Start 2019-01-02 (actual); primary completion 2021-08-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SAPT Versus DAPT in Incomplete Revascularization After CABG
- Acronym
- SDAT-IRC
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- acetylsalicylic acid
- Lead sponsor
- Campus Bio-Medico University
Record details
- Record id
cardio:ct-nct03789916- Content hash
0461a403b475ef7911a56b0041ec491597a9972c7c09fa18a8b70259b77fae1d